Intrabiotics Pharmaceuticals

BiotechnologySeries HLafayette, US

Latest round

Series H

Last raised

Nov 1999

Total raised

$25M

Investors

2

About Intrabiotics Pharmaceuticals

Intrabiotics Pharmaceuticals, is based in Lafayette, US and is a biopharmaceutical company developing novel antibacterial and antifungal drugs for the treatment and prevention of serious infectious diseases.

Who invested in Intrabiotics Pharmaceuticals

2 investors across 1 round

See all investors in Intrabiotics Pharmaceuticals

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series H

    Nov 17, 1999

    Amount

    $25M

    Investors

    Locked

Questions about Intrabiotics Pharmaceuticals

Who invested in Intrabiotics Pharmaceuticals?

Intrabiotics Pharmaceuticals has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Intrabiotics Pharmaceuticals raised?

Intrabiotics Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Intrabiotics Pharmaceuticals last raise money?

Intrabiotics Pharmaceuticals's most recent round on record is a Series H, in Nov 1999.

What does Intrabiotics Pharmaceuticals do?

Intrabiotics Pharmaceuticals, is based in Lafayette, US and is a biopharmaceutical company developing novel antibacterial and antifungal drugs for the treatment and prevention of serious infectious diseases.

Where is Intrabiotics Pharmaceuticals headquartered?

Intrabiotics Pharmaceuticals is headquartered in Lafayette, US.

Which VCs invest in companies like Intrabiotics Pharmaceuticals?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Intrabiotics Pharmaceuticals's stage. Their profiles are linked below.

Raising like Intrabiotics Pharmaceuticals? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.